LungÕ 2026 – Virtual Global Congress on Lung Oncology
FDA Issues New Guidance on Cell and Gene Therapy Potency
L’OncoDaily Session at London Cancer Week 2026: Advancing the Global Conversation on Cancer Care
Cancer Treatment Side Effects: A MedSafetyWeek 2026 Reminder
Ciara Mageean, Olympic Runner and European Champion, Dies at 34 After Stage 4 Bowel Cancer
GDFATHER-NEO: Neoadjuvant Nivolumab + Visugromab in MIBC
Financial Discrimination Against Cancer Survivors: Why the Right to Be Forgotten Is a Global Imperative
Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment
Hematology (OncoDaily Blood) is OncoDaily’s dedicated platform for hematologic oncology, covering the latest research, clinical advances and expert perspectives. Its coverage spans the major hematologic malignancies: acute and chronic leukemias, Hodgkin and non-Hodgkin lymphomas, multiple myeloma and other plasma cell disorders, myelodysplastic and myeloproliferative neoplasms. OncoDaily Blood follows advances in the understanding, diagnosis and treatment of blood cancers, with a focus on emerging strategies, targeted therapies, immunotherapies, CAR-T cell therapy, hematopoietic stem cell transplantation, and molecular and measurable residual disease testing. It reports on practice-changing clinical trials, major hematology congresses, treatment guidelines, regulatory approvals and real-world evidence.
